Skin reactions to amifostine are considered to be rare. Here we describe the case of a patient who developed a severe skin eruption (Stevens-Johnson syndrome) during radiotherapy probably due to amifostine. As in most of the patients described so far, the worst lesions were located in the skin areas previously treated with radiotherapy.
CulyC.R., SpencerC.M.: Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs, 61: 641–684, 2001.
2.
RadesD., FehlaurerF., BajrovicA., MahlmannB., RichterE., AlbertiW.: Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol, 70: 261–264, 2004.
3.
McCauleyD.L.: Amifostine. A novel cytoprotective agent. Cancer Pract, 5: 189–191, 1997.
4.
DorrR.T., HolmesB.C.: Dosing considerations with amifostine: a review of literature and clinical experience. Semin Oncol,26(Suppl 7): 108–119, 1999.
5.
Lale AtahanI., OzyarE., SahinS., YildizF., YalcinB., KaradumanA.: Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy. Br J Dermatol, 143: 1072–1073, 2000.
6.
DemiralA.N., YerebakanO., SimsirV., AlpsoyE.: Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report. Jpn J Clin Oncol, 32: 477–479, 2002.
7.
BocciaR., AnneP.R., BourhisJ., BrizelD., DalyC., HollowayN.3rd, HymesS., KoukourakisM., KozloffM., TurnerM., WassermanT.: Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys, 60: 302–309, 2004.
8.
RoujeauJ.C.: The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol, 102: 28–30, 1994.
9.
FleischerA.B.Jr., RosenthalD.I., BernardS.A., O'KeefeE.J.: Skin reactions to radiotherapy – a spectrum resembling erythema multiforme: case report and review of the literature. Cutis, 49: 35–39, 1992.
